Loading Events
  • This event has passed.

Douglas J. Jolly, PhD,

Executive VP Research & Pharmaceutical Development,

Tocagen, Inc. –

Toca511 – A retroviral replicating vector encoding a prodrug activating gene and a potential therapeutic for recurrent primary brain cancer in clinical trials

 

 

Details

Date:
February 21, 2014
Time:
12:00 PM - 1:00 PM
Event Category:
Website:
http://cvr.bio.uci.edu/

Venue

F-114 Tamkin Student Lecture Building
Irvine, CA 92697 United States

Organizer

Jo Ellen Brunner
Phone:
949-824-9314
Email:
jbrunner@uci.edu
Website:
http://cvr.bio.uci.edu/

« All Events